AstraZeneca PLC
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca Phase II & Phase III NME or major LCM projects in by Quarter
Phase II & Phase III NME or major LCM projects in pipeline (count)
AstraZeneca Phase II & Phase III NME or major LCM projects in: 116 in Q2 2026, down 12.1% from a year earlier. That is the lowest of the 11 quarters on record here.
Where the Q2 2026 figure comes from
“183 projects in development pipeline | 21 NMEs in late-stage pipeline | 116 NME or major LCM projects in Phase II or Phase III | 29 regulatory approvals in major markets (US, EU, CN, JP)”
Source: Clinical Trials Appendix (2026Q2) ↗
Reported in Clinical Trials Appendix (Pipeline at a glance).
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Phase II & Phase III NME or major LCM projects in pipeline (count) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 116 | -12.1% | Clinical Trials Appendix (2026Q2) ↗ |
| Q1 2026 | Mar 31, 2026 | 118 | -10.6% | Clinical Trials Appendix (2026Q1) ↗ |
| Q4 2025 | Dec 31, 2025 | 125 | -3.8% | Clinical Trials Appendix (2025Q4) ↗ |
| Q3 2025 | Sep 30, 2025 | 122 | -12.2% | Clinical Trials Appendix (2025Q3) ↗ |
| Q2 2025 | Jun 30, 2025 | 132 | +0.8% | Clinical Trials Appendix (2025Q2) ↗ |
| Q1 2025 | Mar 31, 2025 | 132 | +7.3% | Clinical Trials Appendix (2025Q1) ↗ |
| Q4 2024 | Dec 31, 2024 | 130 | +5.7% | Clinical Trials Appendix (2024Q4) ↗ |
| Q3 2024 | Sep 30, 2024 | 139 | – | Clinical Trials Appendix (2024Q3) ↗ |
| Q2 2024 | Jun 30, 2024 | 131 | – | Clinical Trials Appendix (2024Q2) ↗ |
| Q1 2024 | Mar 31, 2024 | 123 | – | Clinical Trials Appendix (2024Q1) ↗ |
| Q4 2023 | Dec 31, 2023 | 123 | – | Clinical Trials Appendix (2023Q4) ↗ |
Cite this data
StockData. (2026). AstraZeneca Phase II & Phase III NME or major LCM projects in, quarterly Q4 2023–Q2 2026 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/cta-ph2-ph3-projects
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.